Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Why does thrombolysis fail? Breaking through the reperfusion ceiling

J L Anderson

    The American Journal of Cardiology
    |January 7, 1998
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Mind the gap: decreasing disparities in care for transgender patients.

    Education for primary care : an official publication of the Association of Course Organisers, National Association of GP Tutors, World Organisation of Family Doctors·2025
    Same author

    Evaluation of the effects of water quality on drinking preferences of heifer calves.

    JDS communications·2022
    Same author

    Effects of yeast culture supplementation on lactation performance and rumen fermentation profile and microbial abundance in mid-lactation Holstein dairy cows.

    Journal of dairy science·2021
    Same author

    Effects of peripartal yeast culture supplementation on lactation performance, blood biomarkers, rumen fermentation, and rumen bacteria species in dairy cows.

    Journal of dairy science·2021
    Same author

    Symposium review: Strategies to improve the efficiency and profitability of heifer raising.

    Journal of dairy science·2020
    Same author

    Symposium review: Colostrum management and calf nutrition for profitable and sustainable dairy farms.

    Journal of dairy science·2019
    Same journal

    Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

    The American journal of cardiology·2026
    Same journal

    ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

    The American journal of cardiology·2026
    Same journal

    Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

    The American journal of cardiology·2026
    Same journal

    Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

    The American journal of cardiology·2026
    Same journal

    Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

    The American journal of cardiology·2026
    Same journal

    Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

    The American journal of cardiology·2026
    See all related articles

    Thrombolysis, a clot-busting therapy, often fails due to various factors. Enhanced antiplatelet and antithrombin therapies show promise in improving reperfusion rates, potentially breaking the thrombolysis ceiling.

    Area of Science:

    • Cardiology
    • Pharmacology
    • Thrombosis Research

    Background:

    • Thrombolytic therapy is crucial for treating thrombotic events but faces limitations.
    • Initial thrombolysis failure rates range from 15% to 40% due to hemodynamic, mechanical, or fibrinolytic issues.
    • Platelet-rich thrombi present a significant challenge for current thrombolytic regimens.

    Discussion:

    • Pathophysiologic insights suggest combining therapies can overcome thrombolysis resistance.
    • Glycoprotein IIb/IIIa inhibitors represent a promising class of conjunctive antiplatelet agents.
    • Novel antithrombins, including low molecular weight heparins and hirudin, warrant further investigation.

    Key Insights:

    • Improved conjunctive antiplatelet therapy may enhance thrombolysis efficacy.

    Related Experiment Videos

  • More effective antithrombins could significantly improve clot lysis.
  • The combination of advanced antiplatelet and antithrombin strategies may "break the ceiling" of current thrombolysis success rates.

    • Outlook:

    • Future research should focus on optimizing combination therapies for thrombolysis.
    • Clinical trials are needed to validate the effectiveness of enhanced antiplatelet and antithrombin regimens.
    • Achieving reperfusion rates comparable to primary angioplasty is a key future goal.